Q2 FY2026 EarningsQ2 FY2026 results delivered a minor top-line beat with revenue of $583M vs. $582M consensus, while Adjusted EPS of $0.90 significantly exceeded the $0.85 expectation. Reconstructive sales led growth at 8% YoY (6% organic), offsetting a slight reported decline in Prevention & Recovery. Management reaffirmed full-year FY2026 guidance, maintaining confidence in organic growth of 4-6% despite a 'dynamic' macroeconomic outlook for H2.
Overview: Enovis(ENOV) the Revenue is 582.78 M (+3.23%), Beat estimate;the EBIT is 74.8 M (+9.04%), Beat estimate;the EPS is -0.02 (+96.88%), Miss estimate.